Published in Gene Therapy Weekly, December 19th, 2002
The new finding was reported in Atherosclerosis by researchers who work at the University of Pennsylvania in Philadelphia.
Apolipoprotein A-I (apoA-I) is a constituent of high-density lipoprotein and alleviates the formation of arterial blockage in animals with high cholesterol levels, according to D.J. Rader and colleagues. However, new experiments have demonstrated using apoA-I gene therapy in conjunction with cholesterol lowering gene therapy fails to yield significant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.